by Elec23 | Feb 12, 2025 | News&events
According to Save the Children’s data collected in the Istat 2024 study, in Italy, just 16.8% of women aged 25 to 34 with a degree in STEM subjects (science, technology, engineering, and mathematics) are employed, compared to 37% of men. In this context,...
by Elec23 | Feb 4, 2025 | News&events
VisMederi Group believes that successful studies are founded on good partnerships. We are happy to work with Bioclass, Unitech, and Accurange, three firms that play critical roles in supporting our operations and growth. Bioclass is a reliable partner for consulting,...
by Elec23 | Dec 23, 2024 | News&events
On behalf of VisMederi, we are thrilled to share the exciting news about the grand opening of our new Biotech Research Facility in Colle Val d’Elsa. This momentous event, held on December 13th, marked a significant leap forward for our organization, reinforcing our...
by Elec23 | Nov 5, 2024 | News&events
VisMederi is pleased to announce its inclusion in the distinguished 2023 list of the 300 fastest-growing companies, published by the Financial Times in partnership with Statista. VisMederi is proud to be ranked #188 among the leading organizations that have made great...
by Elec23 | Nov 4, 2024 | News&events
VisMederi Group is pleased to announce the publication of our latest collaborative research with GlaxoSmithKline’s Vaccine Global Health Institute (GVGH) in Frontiers in Immunology. This study addresses a critical challenge in global health: the prevention and control...
by Elec23 | Oct 18, 2024 | News&events
VisMederi is pleased to announce the publishing of a collaborative study with GVGH (GSK Vaccines Institute for Global Health) that highlights a significant achievement in vaccine research. This recent study, published in Frontiers in Immunology, describes the creation...
